Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DERIC SAVIOR

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1912183765
CMS profile
313459
Location
WYNNEWOOD, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$69,296.15

232 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
Regeneron Healthcare Solutions, Inc. $23,367.92 25
Janssen Biotech, Inc. $18,877.38 26
JAZZ PHARMACEUTICALS INC. $14,113.23 21
Boehringer Ingelheim Pharmaceuticals, Inc. $5,368.72 4
EMD Serono, Inc. $2,148.71 3
E.R. Squibb & Sons, L.L.C. $1,769.35 5
Novartis Pharmaceuticals Corporation $281.81 13
AstraZeneca Pharmaceuticals LP $255.35 11
Boston Scientific Corporation $247.75 2
Astellas Pharma US Inc $216.50 9
Caris MPI, Inc. $204.31 4
Incyte Corporation $197.59 12
Daiichi Sankyo Inc. $133.95 5
ABBVIE INC. $133.05 7
GlaxoSmithKline, LLC. $121.43 6
Merck Sharp & Dohme LLC $117.46 5
BeOne Medicines USA, Inc. $117.15 5
Gilead Sciences, Inc. $110.34 4
Tempus AI, Inc $109.62 5
Eisai Inc. $101.75 4
Genentech USA, Inc. $97.59 4
Kite Pharma, Inc. $86.38 4
Celgene Corporation $84.49 3
GENZYME CORPORATION $77.48 3
Alexion Pharmaceuticals, Inc. $72.80 3
Bayer Healthcare Pharmaceuticals Inc. $72.64 3
Takeda Pharmaceuticals U.S.A., Inc. $66.96 3
SOBI, INC $60.18 3
ARRAY BIOPHARMA INC $59.77 3
Genmab U.S., Inc. $58.72 2
Legend Biotech USA Inc. $55.17 2
Pharmacosmos Therapeutics Inc. $53.59 3
BeiGene USA, Inc. $49.97 2
Lilly USA, LLC $46.83 2
Novocure Inc. $43.13 2
TerSera Therapeutics LLC $39.88 2
Exelixis Inc. $35.84 2
TAIHO ONCOLOGY, INC. $32.54 1
Acrotech Biopharma Inc. $29.16 1
PharmaEssentia USA Corporation $27.96 1
SERVIER PHARMACEUTICALS LLC $26.41 1
Aveo Pharmaceuticals, Inc. $25.32 1
Stemline Therapeutics Inc. $21.34 1
Ipsen Biopharmaceuticals, Inc $20.46 1
ADC THERAPEUTICS AMERICA, INC. $20.08 1
PROGENICS PHARMACEUTICALS, INC. $19.67 1
Sumitomo Pharma America, Inc. $18.42 1

Page 3 of 5; records 101–150 of 232 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DERIC SAVIOR

NPI 1912183765 · CMS profile ID 313459

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

WYNNEWOOD, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 5; records 101–150 of 232 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1912183765?year=2025&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DERIC SAVIOR, NPI 1912183765, CMS profile ID 313459. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 232 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1912183765?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). DERIC SAVIOR, NPI 1912183765, CMS profile ID 313459. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 232 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1912183765?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
DERIC SAVIOR, NPI 1912183765, CMS profile ID 313459, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 5; records 101–150 of 232 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1912183765?year=2025&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

232 matching records · $69,296.15 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 232 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 232.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ARRAY BIOPHARMA INC $21.1108/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230309777 CMS
Eisai Inc. $26.8808/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244476324 CMS
GENZYME CORPORATION $23.8208/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233413472 CMS
Incyte Corporation $23.7007/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226035421 CMS
JAZZ PHARMACEUTICALS INC. $355.1707/30/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1234301825 CMS
E.R. Squibb & Sons, L.L.C. $32.2907/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184742231 CMS
Janssen Biotech, Inc. $18.5307/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174673861 CMS
GlaxoSmithKline, LLC. $23.2207/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191534344 CMS
Novartis Pharmaceuticals Corporation $25.0207/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200490924 CMS
Janssen Biotech, Inc. $27.2207/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174673874 CMS
AstraZeneca Pharmaceuticals LP $15.7907/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206349996 CMS
Genentech USA, Inc. $25.0007/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211508520 CMS
Caris MPI, Inc. $22.9807/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234286266 CMS
Novartis Pharmaceuticals Corporation $23.7807/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200490920 CMS
ABBVIE INC. $17.9307/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204080284 CMS
Regeneron Healthcare Solutions, Inc. $217.4807/12/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1213032971 CMS
Astellas Pharma US Inc $23.8507/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238803661 CMS
Alexion Pharmaceuticals, Inc. $24.6107/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202974586 CMS
Genentech USA, Inc. $25.7207/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211508514 CMS
JAZZ PHARMACEUTICALS INC. $40.0107/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234314087 CMS
Legend Biotech USA Inc. $28.9807/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236483660 CMS
Acrotech Biopharma Inc. $29.1607/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1237536424 CMS
Incyte Corporation $24.5706/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226060513 CMS
Aveo Pharmaceuticals, Inc. $25.3206/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1199897896 CMS
Regeneron Healthcare Solutions, Inc. $189.1106/26/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1213032969 CMS
Regeneron Healthcare Solutions, Inc. $246.4406/25/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1213032967 CMS
TAIHO ONCOLOGY, INC. $32.5406/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211409226 CMS
AstraZeneca Pharmaceuticals LP $19.3506/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206508893 CMS
EMD Serono, Inc. $17.2506/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236905393 CMS
Tempus AI, Inc $16.1906/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250351430 CMS
Novartis Pharmaceuticals Corporation $20.3306/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200490922 CMS
Regeneron Healthcare Solutions, Inc. $387.0006/17/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1213032961 CMS
Regeneron Healthcare Solutions, Inc. $25.5006/17/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1213032963 CMS
Regeneron Healthcare Solutions, Inc. $3,882.0006/17/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1213032965 CMS
Regeneron Healthcare Solutions, Inc. $105.9206/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1213032959 CMS
ABBVIE INC. $16.4306/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204080278 CMS
Pharmacosmos Therapeutics Inc. $23.7706/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250730608 CMS
SOBI, INC $15.4206/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240283090 CMS
Regeneron Healthcare Solutions, Inc. $26.7406/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1213032957 CMS
Kite Pharma, Inc. $24.7006/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212089119 CMS
JAZZ PHARMACEUTICALS INC. $35.1006/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234317644 CMS
JAZZ PHARMACEUTICALS INC. $123.4205/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234306684 CMS
JAZZ PHARMACEUTICALS INC. $48.8205/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234313497 CMS
Genentech USA, Inc. $21.8705/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211508518 CMS
ARRAY BIOPHARMA INC $16.5505/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230077446 CMS
Astellas Pharma US Inc $31.1805/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238793943 CMS
Novartis Pharmaceuticals Corporation $36.8505/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200490918 CMS
Genmab U.S., Inc. $30.9805/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235919318 CMS
Caris MPI, Inc. $32.1305/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234286263 CMS
AstraZeneca Pharmaceuticals LP $23.1205/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206618362 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $37,036.11 42
PY2020 $29,304.65 21
PY2021 $67,665.15 58
PY2022 $36,554.73 127
PY2023 $51,787.96 189
PY2024 $51,672.39 223
PY2025 $69,296.15 232

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $51,350.00 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $950.00 07/08/2025 Non-covered Recipient Entity
LANKENAU INSTITUTE FOR MEDICAL RESE ARCH
A Phase 2b, Open-Label, Two-cohort Study of Subcutaneous Amivantamab in Combination with Lazertinib as First-Line Treatment, or Subcutaneous Amivantamab in Combination with Platinum-Based Chemotherapy as Second-line Treatment, for Common EGFR-Mutated Loc No dispute reported 06/30/2026 1175342374
Principal investigator 1 Janssen Research & Development, LLC $14,000.00 07/04/2025 Non-covered Recipient Entity
LANKENAU INSTITUTE FOR MEDICAL RESE ARCH
A Phase 2b, Open-Label, Two-cohort Study of Subcutaneous Amivantamab in Combination with Lazertinib as First-Line Treatment, or Subcutaneous Amivantamab in Combination with Platinum-Based Chemotherapy as Second-line Treatment, for Common EGFR-Mutated Loc No dispute reported 06/30/2026 1175342381
Principal investigator 1 Janssen Research & Development, LLC $36,400.00 06/16/2025 Non-covered Recipient Entity
LANKENAU INSTITUTE FOR MEDICAL RESE ARCH
A Phase 2b, Open-Label, Two-cohort Study of Subcutaneous Amivantamab in Combination with Lazertinib as First-Line Treatment, or Subcutaneous Amivantamab in Combination with Platinum-Based Chemotherapy as Second-line Treatment, for Common EGFR-Mutated Loc No dispute reported 06/30/2026 1175342368